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Abstract
Background: Persons with multiple sclerosis may benefit from hospital-based multidisciplinary
rehabilitation.
Objectives: To investigate the effects of hospital-based multidisciplinary rehabilitation and to identify
their potential predictors in a large sample of persons with multiple sclerosis.
Methods: From the charts of 655 persons with multiple sclerosis consecutively admitted to our unit,
disease profiles, modified Barthel index, Expanded Disability Status Scale (EDSS), pain numerical
rating score and type of interventions were retrospectively collected. We defined an improvement at
discharge as follows: modified Barthel index increase of at least 5 points, EDSS decrease of 1.0 if
baseline score was 5.5 or less and of 0.5 if baseline score was greater than 5.5; any numerical rating
score decrease.
Results: After a median admission period of 36 days, at discharge 65%, 22% and 89% of persons with
multiple sclerosis improved for modified Barthel index, EDSS and numerical rating score, respectively.
The modified Barthel index improvement was associated with shorter disease duration, lower EDSS at
baseline and with access to psychological counselling. EDSS improvement was associated with shorter
disease duration, relapsing–remitting course, female gender and longer duration of the admission period.
Conclusions: Inpatient multidisciplinary rehabilitation was associated with improved autonomy in
activities of daily living in a relevant proportion of persons with multiple sclerosis. The effect seems
to be more evident in individuals with shorter multiple sclerosis duration and relapsing–remitting dis-
ease course.
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Introduction
Multiple sclerosis (MS) is a chronic demyelinating
disease of the central nervous system, in which both
inflammation and irreversible neuroaxonal damage
can be present from the early stages.1 This may pro-
voke moderate to severe physical, cognitive and psy-
chological disabilities. Moreover, pain is a common
symptom in MS by up to 75% of patients. It is,
therefore, widely recognised that, beyond the man-
agement of disease-modifying therapies (DMTs),
MS requires a multidisciplinary care, including
rehabilitation. Rehabilitation can be defined as a
process that helps a person to achieve and maintain
maximal physical, psychological, social and voca-
tional potential, and quality of life (QoL) consistent
with impairment, environment and life goals. In
principle, rehabilitation interventions for persons
with multiple sclerosis (PwMS) may include exer-
cise, functional training, equipment prescription,
provision of assistive technology, orthotics prescrip-
tion, teaching of compensatory strategies, caregiver/
family support and education, counselling and
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referral to community resources. These can be tar-
geted for a variety of impairments, such as mobility,
fatigue, pain, dysphagia, bladder/bowel dysfunction,
decreased independence in activities of daily living
(ADL), communication, QoL, affective disorders
and cognitive dysfunction.2 Several pieces of evi-
dence confirm that rehabilitation is an effective
intervention for PwMS,3 even though no consensus
on a ‘best practice’ approach has been reached yet.
It is worth remembering that generating evidence in
rehabilitation research is more complex than in other
medical fields, as the design and conduct of placebo
controlled, double-blind studies is extremely diffi-
cult. Another problem is to find appropriate outcome
measures, fully encompassing the actual disability of
PwMS, to investigate the effectiveness of the
interventions.4,5
According to the individual patient needs, rehabili-
tation can be administered with different protocols
and settings. Among them, hospital-based multidis-
ciplinary rehabilitation (MDR) has the advantage of
allowing the administration of multiple interventions
in a protected environment and, thereby, guarantee-
ing intensity, adherence and feasibility even for
more disabled patients. Several studies have indicat-
ed that inpatient MDR can reduce disability and
improve QoL in PwMS6–8 compared with no inter-
vention. It remains to be established how long the
effects of inpatient MDR last after discharge and
what is the actual cost-effectiveness of this interven-
tion, which requires relevant health service and com-
munity resources,9,10 thereby often limiting the
access to a minority of PwMS.11,12
Against this background, profiling the best candidates
for inpatient MDR can be useful to enhance the effec-
tiveness of this intervention and to optimise the use of
available resources. To the best of our knowledge,
two studies13,14 have investigated whether the effec-
tiveness of inpatient MDR can be predicted by the
clinical characteristics of PwMS at treatment initia-
tion. Those studies, which were conducted in relative-
ly small cohorts and using different outcomes,
achieved conflicting results, confirming that inpatient
MDR leads to a significant improvement in function-
al status in the majority of treated PwMS, but identi-
fying different possible predictors of such an effect.
While Grasso and coworkers13 found that the effec-
tiveness of MDR seems to be higher in patients with
mild to moderate than in those with severe MS,
Liberatore and colleagues14 reported that a more
severe baseline impairment, a shorter MS duration
and a relapsing–remitting (RR) disease course were
predictive of rehabilitation effectiveness. With the
present retrospective study we investigated, in a
large single centre cohort of PwMS, whether clinical
and demographic characteristics can be predictors of
inpatient MDR effectiveness at discharge on limita-
tions in ADL and on locomotor disability, with the
aims to assess the impact of MDR in a real-life, hos-
pital-based context and to understand better which
individuals most benefit from this type of treatment.
Materials and methods
All patients with MS consecutively admitted to the
Neurorehabilitation Unit, MS Center, Scientific
Institute Don Gnocchi (Milan) from July 2011 to
June 2016 were selected for the present retrospective
study. The unit is part of a scientific institute for
rehabilitation which is not linked to an acute-care
general hospital. The institute also hosts a centre
for MS care and research, where PwMS can have
access to multidisciplinary care including DMT if
indicated. The criteria for admission to inpatient
MDR were the presence of two or more moderate
neurological disabilities at clinical evaluation and a
recent (i.e. within 6 months) functional deterioration.
For all patients fulfilling these criteria MDR pro-
grammes were publicly subsidised and fully reim-
bursed by the national health system. All admitted
patients were enrolled in an intensive rehabilitation
programme consisting of daily sessions from
Monday to Saturday for a total of at least
500 minutes a week. The programme was based on
a multidisciplinary evaluation assessing the patients’
needs and the possible goals, performed by a neurol-
ogist together with a physical medicine and rehabil-
itation specialist. When needed, other evaluations
(cognitive, urological, ophthalmological, respiratory,
etc.) were performed to define the programme.
Interventions may include physiotherapy, occupa-
tional therapy (including assessment and eventually
prescription of adequate aids), respiration therapy,
cognitive rehabilitation, speech and swallowing
rehabilitation, physical therapy for pain (e.g. mas-
sage therapy, transcutaneous electrical nerve stimu-
lation, electrical stimulation, ionophoresis) and
formal psychological counselling. The duration of
the admission was established following an interme-
diate re-assessment of the programme and goals per-
formed by the MDR team (physicians, therapists and
nurses) after 2–3 weeks of admission. Our unit being
part of a scientific institute, all subjects had provided
informed consent to the use of clinical data collected
during the admission for research purposes and no
procedures other than the standard ones were per-
formed for the present study.
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From the clinical charts, we retrieved subjects’ dem-
ographics, disease duration, disease phenotype,
ongoing therapies for MS, modified Barthel index
(mBI),15 Expanded Disability Status Scale
(EDSS),16 pain numerical rating score (NRS)17 and
types of intervention administered. Clinical scales
were rated at admission and discharge. When multi-
ple admissions of the same subject occurred during
the study time frame, only the first (i.e. the oldest)
one was considered. All these pieces of information
were collected by a single observer (EG) in a data-
base and anonymised for data analysis. According to
their functional scale scores, patients were classified
into the following categories: for EDSS: A (EDSS
5.5) subjects able to walk without assistance; B
(EDSS 6.0–7.5) subjects walking with support and
increasing limitation; C (EDSS 8.0) wheelchair-
bound subjects; for mBI: 1, subjects with complete
dependency in ADL (mBI 0–24); 2, subjects with
severe dependency in ADL (mBI 25–49); 3, subjects
with moderate dependency in ADL (mBI 50–74); 4,
subjects with mild dependency in ADL (mBI 75–
90); 5, subjects with minimal dependency in ADL
(mBI 91).
Statistical analysis
For collected variables, means and relative standard
deviations (SDs) or medians and interquartile ranges
(IQRs) were calculated. mBI changes between
admission and discharge were analysed using the
Student’s t-test for paired data, while the non-
parametric Wilcoxon test for paired data was used
for EDSS and NRS. A univariable and multivariable
logistic regression analysis was used to assess
whether the clinical and demographic characteristics
of patients at baseline (i.e. age, gender, disease dura-
tion, disease phenotype, mBI score, EDSS score,
pain NRS score), as well as the duration of the
admission and the number of interventions, were
predictors of MDR effects on mBI, EDSS and pain
NRS scores. These latter outcomes were all consid-
ered as the binary dependent variable in each logistic
model (yes/no improvement). Improvement at dis-
charge was defined as follows: for mBI an increase
of at least 5 points,13 for EDSS a decrease of at least
1 point if the score at baseline was 5.5 or less or a
decrease of at least 0.5 point if EDSS at admission
was greater than 5.5.14 For pain NRS any decrease
was considered as an improvement.
An index of MDR effectiveness on mBI was calcu-
lated as follows: MDR effectiveness¼ (discharge
mBI score – admission mBI score)þ (100 – admis-
sion mBI score) 100%, following the formula
proposed by Grasso et al.13 For pain NRS, the
same formula was applied to compute percentage
changes at discharge as follows: (discharge NRS
score – admission NRS score)þ (10 – admission
NRS score) 100%. For interpretation reasons the
mathematical sign of this latter measure was
changed into higher values corresponding to a great-
er improvement. Both mBI and NRS percentage
changes were used as dependent variables in two
linear regression models in which the role of base-
line characteristics on these outcomes was assessed.
For this analysis the disease duration was reported as
a categorical variable with cut-off set at the first
tertile (i.e. 15 years), as the improvement was con-
sistently noted in patients with the shortest disease
duration. Results were reported as odds ratios (ORs)
with the corresponding 95% confidence interval
(CI) for logistic regression and with linear regression
coefficients (with 95% CI) for the linear regression.
An OR greater than 1 corresponded to an increase in
the probability of improvement for the investigated
endpoint, while the opposite was true for ORs less
than 1. Similarly, a regression coefficient greater
than 0 corresponded to a greater improvement on
the corresponding outcome.
To build both the logistic and the linear multivari-
able regression models, variables were selected
among those reported in univariable analysis using
lasso estimator with an information crite-
ria approach.
As few patients showed missing data, no imputation
or replacement of these data was considered.
A P value less than 0.05 was considered statistically
significant. The Stata software (v.14; Stata Corp)
was used for the computations.
Results
The analysis included data from 655 PwMS, with a
female gender predominance (Table 1). Among
them, 70% had either a secondary progressive or a
primary progressive and 30% had a RR disease
course; the median disease duration was 19 years
(range 0–58 years); most subjects (74.5%) were
not taking any DMT. Of these patients, the vast
majority (98.5%) was admitted from home. Most
subjects (80.3%) reported pain at admission. The
MDR programme included at least two types of
interventions; these consisted of physiotherapy in
all subjects, in most of whom it was associated
with physical therapy for pain and occupational ther-
apy (Table 1). The median duration of the admission
period was 36 days (range 29–44 days). The median
Groppo et al.
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number of interventions was four (range one to six);
in 484 (73.9%) subjects, the MDR programme con-
sisted of three or more types of interventions.
At admission, the median EDSS was 6.5 and mBI
was 63 (Table 2). These levels reflect a moderate to
severe impairment of autonomy in ADL and a low
level of mobility in our population, as confirmed by
the categorical distribution of subjects for both mBI
and EDSS scores.
At discharge, according to the predefined cut-offs,
435 of 636 patients (68.4%) showed an improvement
of either mBI or EDSS score. In detail, 413 of 634
patients (65.1%) had an mBI increase of at least 5
points, and 145 of 653 (22.2%) had a significant
EDSS decrease (see the Statistical analysis section
for the cut-off definitions). Both mBI and EDSS
showed an improvement in 123 of 636 (19.3%)
patients. The NRS decreased in 468 of 526 (88.9%)
patients reporting pain at admission. Interestingly, a
significant mBI increase without a EDSS decrease
was observed in 288 of 634 (45.4%) patients, while
the reverse was true only for 20 of 653 (3.1%)
patients. A significant mBI increase at discharge
was observed in 60 of 98 (61.22%), 242 of 384
(63.02%) patients and 73 of 173 (42.2%) with
EDSS scores at baseline of category A, B and C,
respectively. Group comparisons between patients
who showed mBI improvement at discharge and
those who did not showed that the former had
lower EDSS and higher mBI at baseline, were affect-
ed by RRMS in a higher proportion, and more fre-
quently underwent psychological counselling during
the admission period (Table 3). Patients who showed
EDSS improvement at discharge had a shorter disease
duration than those who did not (Table 3).
The multivariate analysis of MDR effect predictors
(Table 4, Figure 1) showed that mBI improvement
was significantly associated with access to psycho-
logical counselling during the admission period, a
shorter disease duration and a lower EDSS score.
EDSS improvement was significantly more frequent
in patients with a shorter disease duration, female
gender, RRMS course and longer admission dura-
tion. Pain NRS improvement was significantly asso-
ciated with higher NRS scores at admission and with
access to psychological counselling during the
admission period.
A greater NRS improvement, when computed as a
percentage change, was significantly associated with
higher NRS and lower EDSS scores at admission
(Table 4); association coefficients indicate that, on
average, NRS percentage improvement at discharge
was 23% greater for one more NRS point and 5.5%
greater for one less EDSS point scored at admission.
A greater MDR effectiveness on mBI was signifi-
cantly associated with higher baseline mBI, shorter
disease duration and RRMS course (Table 4); on
average, patients with disease duration longer than
15 years had a 4% lower MDR effectiveness than
those with shorter disease duration, and patients with
progressive MS a 5% lower effectiveness than those
with RRMS.
Discussion
MS requires a multimodal care, including both phar-
macological therapies and rehabilitation. Hospital-
based rehabilitation, performed by a coordinated
multidisciplinary group, has the advantage of address-
ing multiple needs and guaranteeing intensity,
Table 1. Subject characteristics at baseline











Secondary progressive 344 (52.5)





Residential unit 2 (0.3)
NRS distribution (n¼638)
0 No pain (%) 129 (19.7)
1–10 Any pain (%) 526 (80.3)
Types of intervention (%)
Physiotherapy 655 (100)
Physical therapy for pain 564 (86.1)




Psychological counselling 178 (27.2)
Cognitive rehabilitation 150 (22.9)
Respiration therapy 145 (22.2)
MS: multiple sclerosis; NRS: numerical rating scale
for pain.
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adherence and feasibility in a protected environment.
Its effectiveness in reducing disability and improving
QoL has been repeatedly demonstrated in
PwMS.7,8,10,13,14 With the present study we aimed at
generating additional pieces of evidence about the
effects of inpatient MDR by analysing data from a
large cohort treated in a single centre in a real-life
setting. In addition, we investigated whether subjects’
clinical and demographic characteristics may help to
identify predictive factors of treatment effects.
The study design was observational and retrospec-
tive; source data had been generated prospectively in
a large population of PwMS who were consecutively
admitted to our hospital unit. Most of them were
affected by the progressive form of the disease,
with moderate to high disability (more than 80%
requiring walking support) and limitation in ADL.
The lack of exclusion criteria corroborates the notion
that the population is well representative of the real-
life scenario. The multidisciplinary intervention was
individualised and goal-oriented, thus this study
does not allow the identification of the effectiveness
of a specific treatment programme. Furthermore, we
selected as outcome measures of MDR effectiveness
both a widely applied scale for ADL (i.e. mBI) and
the commonest disease-specific scale used to quan-
tify neurological disability in MS (i.e. EDSS).
Table 2. Clinical outcomes following MDR.
Admission Discharge
Difference
(discharge vs. admission) P value
EDSS, median (range) 6.5 (3–9.5) 6.5 (1–9.5) –0.18 (0.38; –3.5, 1)a <0.001
Category A, n (%) 98 (15) 129 (19.7)
Category B, n (%) 384 (58.6) 378 (57.7)
Category C, n (%) 173 (26.4) 146 (22.3)
EDSS improved, n (%) 145 (22.2)
Changed category, n (%) 57 (8.7)
From category B to A 31 (4.7)
From category C to B 26 (4.0)
mBI, mean (SD) 54.7 (25.1) 61.5 (26.9) 6.8 (6.5) <0.001
mBI, median (IQR) 63 (38–74) 70 (45.5–82) 5.5 (2–10)
Category 1 (0–24), n (%) 105 (16.6)
Category 2 (25–49) 116 (18.3)
Category 3 (50–74) 256 (40.4)
Category 4 (75–90) 148 (23.3)
Category 5 (91–99) 9 (1.4)
mBI improved, n (%) 413 (65.1%)
Changed category, n (%)
From category 1 to 2 15 (2.4)
From category 2 to 3 45 (7.0)
From category 3 to 4 112 (17.7)
From category 4 to 5 44 (6.9)
Rehabilitation effectiveness,b 20.6 (21.2)
mean (SD)
Rehabilitation effectiveness,b 16.9 (3.9–30.4)
median (IQR)
NRS, mean (SD) 4.7 (2.9) 2.5 (2.3) –2.2 (2.1) <0.001
NRS, median (IQR) 5 (3–7) 2 (0–4) –2 (–3–0)
MDR: multidisciplinary rehabilitation; EDSS: Expanded Disability Status Scale; NRS: numerical rating scale for pain;
mBI: modified Barthel index; IQR: interquartile range; SD: standard deviation.
EDSS categories: A (5.5) ambulation without assistance; B (6.0–7.5) ambulation with support and increasing lim-
itation; C (8.0) wheelchair bound.
mBI categories (degree of dependency): 1, total; 2, severe; 3, moderate; 4, mild; 5, minimal.
aResults are reported as mean (SD; interquartile range).
bSee Materials and methods section for definition and formula.
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Following MDR about two-thirds of these patients
reported a significant improvement of mBI, while a
EDSS decrease was observed in 22% of them. Our
findings are consistent with those from previous
studies and trials in showing the positive effects of
inpatient MDR in MS.7,8,10,13,14 This intervention
lead to a short-term functional improvement in the
majority of admitted PwMS, even if they were
severely limited on a motor ground. Interestingly, a
EDSS decrease without mBI improvement was
reported in very few (about 3%) patients. This sug-
gests that the observed reduction of dependency and
limitations in ADL may not be fully reflected by
changes of a scale which is heavily weighted
towards locomotor impairment and poorly sensitive
to other functional changes. The EDSS score can,
therefore, be viewed as a disease-specific descriptive
scale rather than a complementary outcome measure
of improvement following MDR, especially in
patients with a more severe and long-lasting MS.
On the other hand, mBI captured a significant func-
tional improvement in the majority of our patients,
as did the motor sub-items of the functional indepen-
dence measure (FIM) in the study by Liberatore
et al.,14 in which patients had, on average, less dis-
ability at baseline. The latter difference may,









Age (years), mean (SD) 53.4 (11.6) 55.2 (11.4) 0.059
Female gender, n (%) 263 (63.7) 129 (58.4) 0.20
Disease duration (years), median (IQR) 18 (12–27) 21 (15–29) 0.008
Baseline EDSS, median (IQR) 6.5 (6–7) 7 (6.5–8) <0.001





MS phenotype, n (%) 0.007
RR 142 (34.7) 53 (24.1)
Progressive 267 (65.3) 167 (75.9)
Number of interventions, mean;
median (IQR)
2.95; 3 (2–3) 2.79; 3 (2–3) 0.066
Access to psychological counselling, n (%) 127 (31.5) 47 (21.7) 0.011













Age (years), mean (SD) 52.4 (13.0) 54.4 (11.1) 0.062
Females, n (%) 100 (69) 305 (60) 0.053
Disease duration (years), median (IQR) 18 (11–25) 20 (14–28) 0.008
Baseline EDSS, median (IQR) 7 (6–7.5) 6.5 (6–8) 0.17
MS Phenotype, n (%) 0.051
RR 53/144 (36.8) 142/504 (28.2)
Progressive 91 (63.2) 362/504 (71.8)
Number of interventions, mean; median (IQR) 2.87; 3 (2–4) 2.80; 3 (2–4) 0.45
Access to psychological counselling, n (%) 47 (33.1) 131 (26.3) 0.11







aCalculated from univariable logistic regression with mBI and EDSS improvement status as dependent variables.
mBI: modified Barthel index; EDSS: Expanded Disability Status Scale; SD: standard deviation; IQR: interquartile
range, RR: relapsing–remitting.
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however, explain why, in that population,14 EDSS
was more sensitive to the observed changes than in
our study. mBI is widely used to measure the level of
autonomy in ADL and our findings confirm that it
can be considered a valuable tool for monitoring
functional recovery due to rehabilitation in PwMS.18
We were not able to identify strong clinical predic-
tors of the MDR effectiveness reflected by mBI or
EDSS improvement at discharge. The multivariable
analysis revealed that only a shorter disease duration
was associated with a greater chance of improve-
ment for both these outcomes; for EDSS decrease,
Table 4. Predictors of mBI, EDSS and NRS changes at discharge.
Predictors
OR and regression
coefficients (95% CI) P value
mBI improvement
Psychological counselling (yes vs. no) 1.55 (1.05–2.30) 0.028
Lower disease duration (1 year) 1.02 (1.01–1.04) 0.014
Lower baseline EDSS (1 point) 1.18 (1.02–1.37) 0.031
EDSS improvement
Lower disease duration (1 year) 1.02 (1.00–1.04) 0.021
MS phenotype
Relapsing–remitting vs. progressive 1.75 (1.07–2.88) 0.027
Gender
Female vs. male 1.51 (1.01–2.26) 0.048
Length of admission (days) 1.02 (1.00–1.04) 0.049
NRS decrease (binary)
Baseline NRS (1 point) 2.30 (2.03–2.61) <0.001
Psychological counselling (yes vs. no) 1.74 (0.94–3.20) 0.077
NRS decrease (% change)
Baseline NRS (1 point) 23 (21–25) <0.001
Lower baseline EDSS (1 point) 5.48 (0.79–10.18) 0.022
MDR effectiveness
Baseline mBI (1 point) 0.2 (0.12, 0.28) <0.001
Disease duration (<15 vs. 15 years) 4 (0.7, 7.2) 0.017
MS phenotype (relapsing–remitting vs. progressive) 5 (0.4, 9.6) 0.032
OR: odds ratio; CI: confidence interval; EDSS: Expanded Disability Status Scale; NRS: numerical rating scale for pain; mBI: modified
Barthel index.
See the text for definitions and statistical analysis methods.
Figure 1. Forest plot graphs showing significant baseline predictors of modified Barthel index (mBI), Expanded Disability Status Scale (EDSS)
and numerical rating score (NRS) improvement at discharge (see the text for abbreviations and definitions). Odds ratios (ORs) are shown as mean
values with the corresponding 95% confidence intervals.
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the model retained RR phenotype, female gender
and longer admission period too. Our findings are,
at least partially, consistent with those obtained by
previous studies,13,14 which were, however, charac-
terised by the use of different or additional outcome
measures (i.e. Rivermead mobility index (RMI) and
motor FIM, respectively) and conducted in smaller
samples of subjects. It is also worth noting that, in
both those studies,13,14 the average levels of patients’
disability and impairment at baseline were lower
than in ours and the treatment duration was longer
(about 2 months). Our findings and those from the
other studies13,14 seem, however, to suggest that
functional recovery following inpatient MDR can
be more pronounced in MS subjects with less
severe and long-lasting disease, who may, therefore,
warrant priority of access to this setting.
Interestingly, we found that psychological counsel-
ling was associated with enhanced MDR effects on
mBI and this confirms the importance of patients’
motivation and mood in achieving functional
improvement.
Even though systematic reviews provide strong evi-
dence of the short-term effectiveness of multi-
disciplinary packages of care in improving activities
and participations in PwMS,6 determining the actual
benefit of inpatient MDR remains challenging, also
because its effectiveness is a complex variable to
define and quantify. First of all, MDR programmes
must be individualised and can include a wide range
of interventions depending on the goals and on the
patient needs and priorities. Therefore, it is not sur-
prising that, having limited our evaluation to a com-
prehensive and non-specific functional scale such as
the mBI, we may not have fully encompassed the
impact of MDR on the multiple dysfunctions caused
by MS. Recently, Barin and colleagues19 assessed
the concurrent validity and relative responsiveness
of a multidimensional outcome measure core set,
including FIM, RMI, the 2-Minute Walk Test,
Timed 25-Foot Walk test and Nine-Hole Peg Test,
in a population of inpatients with progressive MS
admitted to a neurorehabilitation centre. In this
study, for PwMS with EDSS of 7 or greater the
only responsive measures were RMI and FIM
motor, indicating that high EDSS scores may be
associated with a lesser sensitivity to changes for
scales mainly reflecting motor abilities.19 Other
researchers used outcome measures of inpatient
MDR focused on health-related QoL rather than on
functional/motor impairment.10 They reported a sig-
nificant effectiveness of inpatient MDR on two
measures of QoL, which was persistent 6 months
after discharge.10 All those studies10,13,14,19 consis-
tently show the effectiveness of inpatient MDR on
different outcomes and seem to suggest that a com-
posite measure reflecting both functioning (e.g. mBI,
FIM and other mobility scales) and QoL might fully
encompass and assess the ‘global’ impact of this
intervention. Perhaps only the integration between
the International Classification of Functioning,
Disability and Health (ICF) and outcome measure
scales18 might enable us to obtain reliable and com-
prehensive measures and to facilitate the conduct of
multicentre studies to address this issue better.
Admittedly, our study had several limitations. These
include the retrospective design, the high variability
of interventions and the use of ‘generic’ scales rated
by different observers, who were, however, skilled
physicians in MS care and functional scale adminis-
tration. In particular, the assessment of changes in
EDSS may have also been limited by the well-
known subjectivity of this scale.20 As regards the
described effects of MDR on pain intensity, it is
worth remembering that NRS remains a subjective
scale, which was not specifically set and validated
for MS and that PwMS may simultaneously experi-
ence pain of heterogeneous causes and types, includ-
ing neuropathic, musculoskeletal and ‘mixed’ pain
in both continuous and intermittent ways.21,22 All of
this may, on the one hand, explain the very high
prevalence of pain in our population of aged and
severely disabled PwMS, which remains, however,
consistent with the frequency of pain complaints
described in MS studies.21 On the other hand,
these considerations make it difficult to interpret
the actual impact of inpatient MDR programmes
on pain in the absence of more specific measures.
Moreover, we do not have data about the post-
discharge effects of MDR (i.e. duration and impact
on ADL at home). Nevertheless, to the best of our
knowledge, it reports findings from the largest
sample of PwMS consecutively admitted to a
single rehabilitation unit, thereby providing us with
‘real-life’ data without selection or effectiveness
bias. Beyond the confirmation that inpatient MDR
seems to be able to improve the autonomy in most
PwMS, our results seem to indicate that such an
effect, albeit stronger in individuals with shorter dis-
ease duration, lesser neurological disability and RR
course, is maintained in those with a long-lasting and
severely disabling disease. This suggests that inpa-
tient MDR, despite its well-known costs, must be
available to ensure the best disease management to
all PwMS, once its objectives and goals are defined.
Additional studies are warranted to clarify what
Multiple Sclerosis Journal—Experimental, Translational and Clinical
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could be the best outcomes to measure reliably the
inpatient MDR effectiveness size and its duration
over time, as well as to compare it with that of reha-
bilitation administered in other settings.
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effectiveness of inpatient multidisciplinary rehabilita-
tion on health-related quality of life in MS patients: a
pragmatic randomized controlled trial – The Danish
MS Hospitals Rehabilitation Study. Mult Scler 2018;
24: 340–349.
11. Ponzio M, Gerzeli S, Brichetto G, et al. Economic
impact of multiple sclerosis in Italy: focus on rehabil-
itation costs. Neurol Sci 2015; 36: 227–234.
12. Tacchino A, Brichetto G, Zaratin P, et al. Multiple
sclerosis and rehabilitation: an overview of the differ-
ent rehabilitation settings. Neurol Sci 2017;
38: 2131–2138.
13. Grasso MG, Pace L, Troisi E, et al. Prognostic factors
in multiple sclerosis rehabilitation. Eur J Phys Rehabil
Med 2009; 45: 47–51.
14. Liberatore G, Clarelli F, Nuara A, et al. Predictors of
effectiveness of multidisciplinary rehabilitation treat-
ment on motor dysfunction in multiple sclerosis. Mult
Scler 2014; 20: 862–870.
15. Mahoney FI and Barthel DW. Functional evaluation:
the Barthel Index. Md State Med J 1965; 14: 61–65.
16. Kurtzke JF. Rating neurologic impairment in multiple
sclerosis: an expanded disability status scale (EDSS).
Neurology 1983; 33: 1444–1452.
17. Ferreira-Valente MA, Pais-Ribeiro JL and Jensen MP.
Validity of four pain intensity rating scales. Pain
2011; 152: 2399–2404.
18. Prodinger B, O’Connor RJ, Stucki G, et al.; on behalf
of the ICF INFO Network. Establishing score equiva-
lence of the Functional Independence Measure motor
scale and the Barthel Index, utilizing the International
Classification of Functioning, Disability and Health
and Rasch measurement theory. J Rehabil Med
2017; 49: 416–422.
19. Barin L, Vaney C, Puhan MA, et al. Recommended
outcome measures for inpatient rehabilitation of mul-
tiple sclerosis are not appropriate for the patients with
substantially impaired mobility. Mult Scler Relat
Disord 2018; 22: 108–114.
20. Meyer-Moock S, Feng YS, Maeurer M, et al.
Systematic literature review and validity evaluation
of the Expanded Disability Status Scale (EDSS) and
the Multiple Sclerosis Functional Composite (MSFC)
in patients with multiple sclerosis. BMC Neurology
2014; 14: 58.
21. O’Connor AB, Schwid SR, Herrmann DN, et al. Pain
associated with multiple sclerosis: systematic review
and proposed classification. Pain 2008; 137: 96–111.
22. Solaro C, Trabucco E and Messmer Uccelli M. Pain
and multiple sclerosis: pathophysiology and treatment.
Curr Neurol Neurosci Rep 2013; 13: 320.
Groppo et al.
www.sagepub.com/msjetc 9
